# Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies

> **NCT04684979** · PHASE2 · WITHDRAWN · sponsor: **Baptist Health South Florida**

## Conditions studied

- B-Cell Lymphoid Malignancies
- Hematologic Malignancy
- Non-Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** Hematopoietic Stem Cells from HLA-compatible Related
- **BIOLOGICAL:** Hematopoietic Stem Cells from HLA Unrelated

## Key facts

- **NCT ID:** NCT04684979
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-28
- **Primary completion:** 2026-03
- **Final completion:** 2027-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The landscape of treatment for patients targeted for enrollment has significantly changed since the protocol was written and approved, and the research treatment is no longer the best option for this population.
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684979, "Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04684979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*